Evidence map›Paper›PMID 33960368›Full record

ArticleThe Biochemical journal2021

Characterization of the structural determinants of the ubiquitin-dependent proteasomal degradation of human hepatic tryptophan 2,3-dioxygenase.

Yi Liu, Sung-Mi Kim, YongQiang Wang, Shay Karkashon, Ariel Lewis-Ballester, Syun-Ru Yeh, Maria Almira Correia

Open access · hybridAbstract read
In one paragraph

Article in The Biochemical journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 64% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Heme-based dioxygenases: Structure, function and dynamics.Journal of inorganic biochemistry · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yi LiuDepartments of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA 94158-2517, U.S.A.
Sung-Mi KimDepartments of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA 94158-2517, U.S.A.
YongQiang WangDepartments of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA 94158-2517, U.S.A.
Shay KarkashonDepartment of Physiology and Biophysics, Albert Einstein College of Medicine Bronx, New York, NY 10461, U.S.A.
Ariel Lewis-BallesterDepartment of Physiology and Biophysics, Albert Einstein College of Medicine Bronx, New York, NY 10461, U.S.A.
Syun-Ru YehDepartment of Physiology and Biophysics, Albert Einstein College of Medicine Bronx, New York, NY 10461, U.S.A.
Maria Almira CorreiaDepartments of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA 94158-2517, U.S.A.ORCID 0000-0002-8939-2180
University of California, San Francisco · USAlbert Einstein College of Medicine · US

Funding

HEPATIC DEGRADATION OF P450P ISOZYMESR01GM044037 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CORREIA, MARIA ALMIRA · 1990 to 2023
$8.0M
Structure and Function of Heme-based DioxygenasesR01GM115773 · NIGMS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI YEH, SYUN-RU · 2016 to 2023
$3.3M
Structures of time-resolved intermediates in cytochrome c oxidase obtained by serial femtosecond crystallographyR01GM126297 · NIGMS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI DENIS L. ROUSSEAU · 2017 to 2026
$3.2M
NIGMS NIH HHS R01 GM044037NIGMS NIH HHS R01 GM115773NIGMS NIH HHS R01 GM126297
6 · The paper itself

Abstract

Human hepatic tryptophan 2,3-dioxygenase (hTDO) is a homotetrameric hemoprotein. It is one of the most rapidly degraded liver proteins with a half-life (t1/2) of ∼2.3 h, relative to an average t1/2 of ∼2-3 days for total liver protein. The molecular mechanism underlying the poor longevity of hTDO remains elusive. Previously, we showed that hTDO could be recognized and ubiquitinated by two E3 ubiquitin (Ub) ligases, gp78/AMFR and CHIP, and subsequently degraded via Ub-dependent proteasomal degradation pathway. Additionally, we identified 15 ubiquitination K-sites and demonstrated that Trp-binding to an exosite impeded its proteolytic degradation. Here, we further established autophagic-lysosomal degradation as an alternative back-up pathway for cellular hTDO degradation. In addition, with protein kinases A and C, we identified 13 phosphorylated Ser/Thr (pS/pT) sites. Mapping these pS/pT sites on the hTDO surface revealed their propinquity to acidic Asp/Glu (D/E) residues engendering negatively charged DEpSpT clusters vicinal to the ubiquitination K-sites over the entire protein surface. Through site-directed mutagenesis of positively charged patches of gp78, previously documented to interact with the DEpSpT clusters in other target proteins, we uncovered the likely role of the DEpSpT clusters in the molecular recognition of hTDO by gp78 and plausibly other E3 Ub-ligases. Furthermore, cycloheximide-chase analyses revealed the critical structural relevance of the disordered N- and C-termini not only in the Ub-ligase recognition, but also in the proteasome engagement. Together, the surface DEpSpT clusters and the N- and C-termini constitute an intrinsic bipartite degron for hTDO physiological turnover.

Indexed as

AutophagyUbiquitinationHep G2 CellsHumansLysosomesMutationPhosphorylationProteasome Endopeptidase ComplexProteolysisTryptophanTryptophan OxygenaseUbiquitinProteasome Endopeptidase ComplexTryptophanTryptophan OxygenaseUbiquitin3-dioxygenasedisordered terminiexositehuman tryptophan 2surface DEpSpT clustersUb-dependent proteasomal degradationα-methyltryptophan

Identifiers

PMID33960368
PMCPMC8892992
OpenAlexW3157172470

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.